These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 7211417)

  • 1. (Gln4)-neurotensin and gastrointestinal motility in man.
    Thor K; Rökaeus A; Kager L; Rosell S
    Acta Physiol Scand; 1980 Nov; 110(3):327-8. PubMed ID: 7211417
    [No Abstract]   [Full Text] [Related]  

  • 2. Antroduodenal motor response induced by (Gln4)-neurotensin in man.
    Thor K; Rökaeus A
    Acta Physiol Scand; 1983 Aug; 118(4):369-72. PubMed ID: 6637541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (Gln4)-neurotensin changes the motility pattern of the duodenum and proximal jejunum from a fasting-type to a fed-type.
    Thor K; Rosell S; Rökaeus A; Kager L
    Gastroenterology; 1982 Sep; 83(3):569-74. PubMed ID: 7095362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of neurotensin in gut motility.
    Rosell S; Al-Saffar A; Thor K
    Scand J Gastroenterol Suppl; 1984; 96():69-75. PubMed ID: 6591383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of gastric and intestinal motor activity in dogs by (Gln4) neurotensin.
    Andersson S; Rosell S; Hjelmquist U; Chang D; Folkers K
    Acta Physiol Scand; 1977 Jun; 100(2):231-5. PubMed ID: 888712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of neurotensin and neurotensin analogues on the migrating myoelectrical complexes in the small intestine of rats.
    Al-Saffar A; Rosell S
    Acta Physiol Scand; 1981 Jun; 112(2):203-8. PubMed ID: 7315414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of neurotensin on gastrointestinal motility in rodents.
    Ayres EA; Fulginiti JT; Porreca F; Peterson LJ; Shook JE; Burks TF
    Proc West Pharmacol Soc; 1985; 28():153-5. PubMed ID: 4070240
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma concentration of neurotensin-like immunoreactivity (NTLI) and lower esophageal sphincter (LES) pressure in man following infusion of (Gln4)-neurotensin.
    Rosell S; Thor K; Rökaeus A; Nyquist O; Lewenhaupt A; Kager L; Folkers K
    Acta Physiol Scand; 1980 Aug; 109(4):369-75. PubMed ID: 7468258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the mechanisms by which (Gln4)-neurotensin reduces lower esophageal sphincter (LES) pressure in man.
    Thor K; Rökaeus A
    Acta Physiol Scand; 1983 Aug; 118(4):373-7. PubMed ID: 6637542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirect vascular actions of (Gln4)-neurotensin in canine adipose tissue.
    Rosell S; Rökaeus A; Chang D; Folkers K
    Acta Physiol Scand; 1978 Feb; 102(2):143-7. PubMed ID: 626094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rectocolonic excitatory reflex or rectocolonic inhibitory reflex?
    Shafik A
    Dis Colon Rectum; 2005 Aug; 48(8):1671-2. PubMed ID: 15937614
    [No Abstract]   [Full Text] [Related]  

  • 12. Relation between lower esophageal sphincter (LES) pressure and the plasma concentration of neurotensin during intravenous infusion of neurotensin(1-13) and (Gln4)neurotensin(1-13) in man.
    Theodorsson-Norheim E; Thor K; Rosell S
    Acta Physiol Scand Suppl; 1983; 515():29-35. PubMed ID: 6578671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vagotomy inhibits the effect of neurotensin on gastrointestinal transit in the rat.
    Hellström PM
    Acta Physiol Scand; 1986 Sep; 128(1):47-55. PubMed ID: 3766174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of neurotensin in disease.
    Rosell S; Rökaeus A; Theodorsson-Norheim E
    Scand J Gastroenterol Suppl; 1983; 82():59-67. PubMed ID: 6579628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance P and neurotensin in the control of gastrointestinal function.
    Rosell S
    Soc Gen Physiol Ser; 1980; 35():147-62. PubMed ID: 6158103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotensin stimulates defaecation.
    Calam J; Unwin R; Peart WS
    Lancet; 1983 Apr; 1(8327):737-8. PubMed ID: 6132085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of neurotensin, substance P and methionine-enkephalin on colonic motility.
    Hellström PM; Rosell S
    Acta Physiol Scand; 1981 Oct; 113(2):147-54. PubMed ID: 6172002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotensin increases net fluid secretion and transit rate in the small intestine of man.
    Wiklund B; Liljeqvist L; Rökaeus A
    Regul Pept; 1984 Jan; 8(1):33-9. PubMed ID: 6718766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of action of neurotensin on microcirculation, metabolism and motility of the small intestine].
    Sendur R; Thor P; Biernat J; Kozioł R; Pawlik WW
    Folia Med Cracov; 1997; 38(3-4):3-15. PubMed ID: 10481377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SR 48692, a specific neurotensin receptor antagonist, has no effect on oesophageal motility in humans.
    Zerbib F; Piche T; Charles F; Galmiche JP; Bruley des Varannes S
    Aliment Pharmacol Ther; 2004 Apr; 19(8):931-9. PubMed ID: 15080855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.